Related Experiment Video
Updated: Jul 4, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
[Prostate specific antigen: utilization modalities and interpretation]
J-M Hannoun-Levi1, A Ginot, J Thariat
1Centre Antoine-Lacassagne, département de radiothérapie, 33, avenue de Valombrose, 06189 Nice cedex, France. jean-michel.hannoun-levi@nice.fnclcc.fr
Abstract:
The prostate specific antigen test has become one of the most popular blood test. However, its result should be analyzed with caution due to physiologic variability. The PSA test is performed for prostate cancer (PC) screening or for post-treatment PC surveillance. According to the applied treatment (surgery or radiation therapy with or without hormonal therapy), PSA analysis can confirm biochemical control or relapse. New PSA data regarding the evolution of this biomarker during the surveillance (PSA doubling time and PSA velocity) are now important to consider in case of biochemical relapse.

